Researchers from Ben-Gurion University reveal that anti-inflammatory drugs interfere with aspirin’s clotting ability, making it near useless for the prevention of heart attacks and strokes in millions of people
Oftentimes, we find that certain medications aren’t quite as useful as we imagined they were, or that they have unwanted side effects. This usually occurs with newer drugs, like Merck’s Vioxx, but now Researchers from the Ben-Gurion University reveal that one of the oldest medications in the book does not work as well as we would like it to. Aspirin’s effect in preventing blood clots appears to be countered by Celebrex and other anti-inflammatory drugs.
This basically means that the millions of elderly Americans who take Celebrex for arthritis or other pains, while also taking a low-dose aspirin tablet daily to reduce the risk of heart attack and stroke, are gaining little to no benefit from the aspirin. This study mirrors a cooperative study conducted at the University of Michigann, Ann Arbor, that showed for the first time that Celebrex and other coxibs directly interfere with the protective qualities of aspirin.
Source – Ben-Gurion University
Popularity: 4% [?]
NewPR – content development, technology, and social media strategies
3 Responses to “BGU Study finds that Anti-inflammatory Drugs Interfere with Aspirin’s Clotting Ability”